Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial - Heise, T; Zijlstra, E; Nosek, L (Diabetes Obes Metab, 2017)
et al.